Pages that link to "Item:Q3549407"
From MaRDI portal
The following pages link to Evaluating Candidate Principal Surrogate Endpoints (Q3549407):
Displaying 28 items.
- Assessing the value of a censored surrogate outcome (Q118842) (← links)
- A causal framework for surrogate endpoints with semi-competing risks data (Q712513) (← links)
- Causal inference: a missing data perspective (Q1799347) (← links)
- Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy (Q2001894) (← links)
- Identification of causal effects within principal strata using auxiliary variables (Q2075703) (← links)
- Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431) (← links)
- Bayesian methods for multiple mediators: relating principal stratification and causal mediation in the analysis of power plant emission controls (Q2281243) (← links)
- Exploiting multiple outcomes in Bayesian principal stratification analysis with application to the evaluation of a job training program (Q2441865) (← links)
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference (Q2827172) (← links)
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials (Q2846433) (← links)
- Using Secondary Outcomes to Sharpen Inference in Randomized Experiments With Noncompliance (Q2861822) (← links)
- Surrogate Measures and Consistent Surrogates (Q2861938) (← links)
- Comparing Biomarkers as Principal Surrogate Endpoints (Q2893405) (← links)
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials (Q3076045) (← links)
- Augmented Designs to Assess Principal Strata Direct Effects (Q3107200) (← links)
- Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling (Q3119801) (← links)
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
- A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials (Q3576929) (← links)
- A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint (Q4649074) (← links)
- A Multiple Imputation Approach for the Evaluation of Surrogate Markers in the Principal Stratification Causal Inference Framework (Q4984852) (← links)
- Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments (Q5850972) (← links)
- Discussion on “Surrogate Measures and Consistent Surrogates” (Q5891277) (← links)
- Discussion on “Surrogate Measures and Consistent Surrogates” (Q5891278) (← links)
- Rejoinder (Q5891280) (← links)
- A unified evaluation of differential vaccine efficacy (Q6047741) (← links)
- Robust methods to correct for measurement error when evaluating a surrogate marker (Q6055522) (← links)
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy (Q6055756) (← links)
- Testing for Heterogeneity in the Utility of a Surrogate Marker (Q6079768) (← links)
